lished chronic congestive cardiac failure of varying etiologies. Of these, the etiology was rheumatic fever in 11, hypertension in 7, coronary arteriosclerosis in 11, combined congenital anomaly and hypertension in one, and cor pulmonale in one patient. Two patients had localized edema; in one due to immobilization and in the other to an unknown cause. Despite the relatively advanced state of their illnesses, marked peripheral edema was uncommon, owing largely to a well controlled, lowsodium intake of less than 800 mg. daily.7 Under this dietary regimen, the need for mercurial diuretics fell sharply.
T HE ROLE of organic mercurial diuretics in treatment of the edema of congestive heart failure and other conditions involving fluid retention is well established. However, because toxic manifestations, including fatalities, occur at times after the administration of these compounds,'-' less toxic mercurial diuretics have been sought. Lehman4 found Thiomerin, the disodium salt of N-('y-carboxymethylmercaptomercuri -, -methoxy) -propyl camphoramic acid, markedly less toxic than other organic mercurial diuretics, as measured by the intravenous dose required to produce electrocardiographic changes in cats. Subsequently, he observed that Thiomerin could be injected subcutaneously in animals without causing local tissue damage or evidence of pain. ' Clinical trial of this potential, subcutaneously administerable diuretic was suggested, first, because Thiomerin is chemically identical with Mercuzanthin (sodium salt of 0-methoxy-,y-hydroxymercuripropylamide of cyclopentane dicarboxylic acid theophylline) except for the substitution of a monothiol for the theophylline; and, second, because monothiols, unlike dithiols which inhibit diuresis, have been demonstrated to reduce the cardiotoxic effects of organic mercurials without affecting diuretic action. 6 MATERIAL AND METHODS The subjects were 21 hospitalized patients and 12 outpatients, most of whom were in well estab- lished chronic congestive cardiac failure of varying etiologies. Of these, the etiology was rheumatic fever in 11, hypertension in 7, coronary arteriosclerosis in 11, combined congenital anomaly and hypertension in one, and cor pulmonale in one patient. Two patients had localized edema; in one due to immobilization and in the other to an unknown cause. Despite the relatively advanced state of their illnesses, marked peripheral edema was uncommon, owing largely to a well controlled, lowsodium intake of less than 800 mg. daily.7 Under this dietary regimen, the need for mercurial diuretics fell sharply.
In general, therapy other than mercurial diuretics was not influenced by our study. Digitalis and quinidine were given as indicated; ambulation was encouraged when the patient's condition permitted it. Ammonium chloride was not given since chloruresis was utilized as a measure of response. To limit the number of variables, adjuvant therapy such as aminophylline was avoided. Mercurials were administered in terms of the patients' needs and by the following routes: Thiomerin generally subcutaneously, Mercuzanthin intravenously, and Mercuhydrin (methoxyoximercuripropylsuccinyl urea) intramuscularly. The dosage of any mercurial never exceeded 2 cc., which is equivalent to 80.0 mg. of mercury; occasionally smaller amounts were used. More than three hundred injections have been given.
In the hospital, diuresis was followed by measuring the volume and chloride concentration of daily twenty-four hour urines. Daily urinary excretion of creatinine was not determined. However, the fairly constant daily chloride excretion on a fixed, low-salt intake indicates the accuracy of the urine collection. Patients were weighed daily on the same scale at about the same time of the morning. Because measurement of fluid intake is frequently unreliable on general hospital wards, these data are not reported.
Patients from whom accurate collections could not be obtained were eliminated from the study.
Outpatients were instructed to return for reweighing at the same hour the day following an injection of a mercurial. Where this was not feasible,GROSSMAN, WESTON, EDELMAN, AND LEITER the patients were asked to weigh themselves on the same scale, at or near their homes on the day of, and the day after, the injection, wearing the same amount of clothing. In a few instances, these patients measured and reported their own twenty-four hour urine output.
In a smaller series of normal subjects and patients in congestive failure, the early effects of Thiomerin and Mercuzanthin on the renal clearances of manmitol, para-amino hippurate, sodium, chloride, and at times, uric acid were studied by the usual constant infusion technic of Smith and his associates as outlined by Goldring Table 1 presents data on the twenty-four hour urinary volume and chloride output of representative patients in congestive failure during control periods and after the administration of Thiomerin subcutaneously and other mercurials intravenously or intramuscularly. In most patients, the twenty-four hour urinary volume after subcutaneous injection of Thiomerin increased 1,000 to 1,500 cc. above control levels. At the same time, there was an approximately tenfold increase in chloride excretion which, in these patients on low-salt intake, averaged 0.2 to 0.3 grams (5.6 to 8.5 meq.) per twenty-four hours, during control periods. However, the responses in individual patients varied. Thus, in Patient M. I., whose daily urine volume and chloride output rarely exceeded 1,000 cc. and 0.3 grams, respectively, urine volume increased to 4,000 cc. with an associated chloride excretion of 12 a rule the changes in water and electrolyte excretion occur simultaneously. When electrolyte output exceeds one-tenth of a milliequivalent per minute, the excretions of sodium and chloride tend to rise and fall to an equal degree so that the two curves of excretion virtually coincide. Generally, no significant change in glomerular filtration rate or renal plasma flow occurs
In table 2 are summarized the data on renal hemodynamics and water and electrolyte excretion before mercurial administration and during the period of maximal diuretic effect. Generally, maximal increase in electrolyte and water output occurred together, but in 3 cases, maximal water diuresis occurred earlier.
The close correspondence between sodium effects of the two routes of administration is the occurrence of diuresis thirty to fifty minutes earlier on intravenous administration. In this patient there also seems to be a more abrupt, somewhat greater, but less sustained rise of diuresis on intravenous administration than on subcutaneous injection. In the other 2 patients, however, there was little difference in the height of maximal response between the two routes of administration (table 2) .
Uric acid excretion was measured in 8 patients prior to and following administration of Thiomerin and MIercuzanthin. The results are summarized in table 3. In figure 2 , the changes in uric acid clearance in a noncardiac patient following intravenous Thiomerin are plotted tion. Similarly, the examination of the urine of several patients who had had repeated injections of Thiomerin revealed no changes from the pretreatment findings, although certain thiols or their mercury complexes have been said to produce hematuria.'5 Apparently, a therapeutic dose, given twice weekly for four to six weeks, does not produce clinically demonstrable renal damage.
Subcutaneous injections of Thiomerin produce no more pain than does any subcutaneous aqueous injection. In more than 300 injections, no systemic reactions of any severity occurred. Two severe local reactions were encountered. The first followed the injection of 2 cc. of Thio- Because of the current emphasis on renal factors in congestive heart failure, it should be stressed that the sodium and water retention of cardiac patients is secondary to a more fundamental impairment in cardiac function. Therefore, therapy must be based on the accepted methods of improvingmyocardial function, such as digitalization and adjustment of activity to the physiologic capacity of the patient. At any stage of decompensation, mercurials are valuable for promoting loss of edema. However, as the patient's cardiac status deteriorates and chronic congestive failure develops, these diuretics and the low-salt diet become even more important.
Ultimately, the marked reduction in cardiac output may result in very severely reduced renal circulation. In this late stage of congestive failure, the very low glomerular filtration rate
